血管-实质交互通过BMPR2信号促进肺纤维化
该研究探讨纤维化肺中血管重塑的发病机制及其对纤维化进展的贡献。研究采用TGF-β1过表达诱导的肺纤维化伴肺动脉高压大鼠模型,并结合纤维化肺病患者样本分析。发现内皮细胞减少、血管平滑肌细胞激活,BMPR2信号降低,他克莫司可激活BMPR2信号并减轻纤维化和肺动脉高压。
要点
- 纤维化肺中内皮细胞减少、血管平滑肌细胞激活,BMPR2信号降低。
- 他克莫司激活BMPR2信号,减轻啮齿类动物肺纤维化和肺动脉高压。
- IPF移植患者存在PH相关基因罕见突变,包括BMPR2。
核心结论
- 肺纤维化继发肺动脉高压中的内皮功能障碍和血管重塑通过BMPR2信号受损增强纤维化生成。
- 他克莫司可能对晚期IPF合并肺动脉高压具有治疗价值。
- 遗传异常可能决定晚期IPF中肺动脉高压的发生。
研究设计与样本
- 采用瞬时过表达活性TGF-β1诱导的肺纤维化伴肺动脉高压实验模型。
- 使用免疫染色、基因表达和基因突变分析深度分析纤维化肺病患者样本。
- 对大鼠和人类纤维化肺组织及细胞共培养体系进行研究。
- 对接受移植的IPF患者进行全外显子测序。
主要发现
- 纤维化肺中内皮细胞减少、血管平滑肌细胞激活。
- 纤维化肺来源的血管平滑肌细胞或内皮细胞与成纤维细胞共培养可诱导成纤维细胞纤维化表型。
- IPF成纤维细胞在共培养体系中诱导内皮细胞死亡和血管平滑肌细胞激活。
- 大鼠和人类纤维化肺的内皮细胞和血管平滑肌细胞中BMPR2浓度及其信号降低。
- 血管平滑肌细胞中BMPR2抑制导致对成纤维细胞的促纤维化效应。
临床怎么用
- 他克莫司可能作为晚期IPF合并肺动脉高压的潜在治疗选择。
- BMPR2信号通路可能成为肺纤维化合并肺动脉高压的干预靶点。
- 对晚期IPF患者可考虑评估PH相关基因突变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by progressive lung scarring. IPF-related pulmonary vascular remodeling and pulmonary hypertension (PH) result in a particularly poor prognosis. Objectives: To study the pathogenesis of vascular remodeling in fibrotic lungs and its contribution to progression of fibrosis. Methods: We used an experimental model of lung fibrosis associated with PH by transient overexpression of active TGF-β1 (transforming growth factor-β1). Samples from patients with fibrotic lung diseases were analyzed in depth using immunostaining, gene expression, and gene mutations. Measurements and Main Results: We found a reduction in endothelial cells (ECs) and activation of vascular smooth muscle cells (VSMCs) in fibrotic lungs. Coculturing fibroblasts with VSMCs or ECs from fibrotic lungs induced fibrotic phenotypes in fibroblasts. IPF fibroblasts induced EC death and activation of VSMCs in coculture systems. Decreased concentrations of BMPR2 (bone morphogenic protein receptor 2) and its signaling were observed in ECs and VSMCs from fibrotic lungs in both rats and humans. On fibroblasts treated with media from VSMCs, BMPR2 suppression in VSMCs led to fibrogenic effects. Tacrolimus activated BMPR2 signaling and attenuated fibrosis and PH in rodent lungs. Whole-exome sequencing revealed rare mutations in PH-related genes, including BMPR2, in patients with IPF undergoing transplantation. A unique missense BMPR2 mutation (p.Q721R) was discovered to have dysfunctional effects on BMPR2 signaling. Conclusions: Endothelial dysfunction and vascular remodeling in PH secondary to pulmonary fibrosis enhance fibrogenesis through impaired BMPR2 signaling. Tacrolimus may have value as a treatment of advanced IPF and concomitant PH. Genetic abnormalities may determine the development of PH in advanced IPF.
引用
- Yanagihara T, Tsubouchi K, Zhou Q, et al. Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling. Am J Respir Crit Care Med. 2023. PMID: 36917778. doi:10.1164/rccm.202109-2174OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。